Skip to content
10-Q

Quarterly Report

CYCLERION THERAPEUTICS, INC. CYCN

0001193125-25-277749

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 3.93M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.23M sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.97M sh
Shares Diluted Q3 2025 · Sep 30, 2024 2.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 2.51M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.74M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$4.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.57M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.54M
Stockholders Equity Q3 2025 · Dec 31, 2024 $8.85M
Current Liabilities Q3 2025 · Sep 30, 2025 $877K
Current Liabilities Q3 2025 · Dec 31, 2024 $725K
Current Assets Q3 2025 · Sep 30, 2025 $5.07M
Current Assets Q3 2025 · Dec 31, 2024 $4.23M
Total Assets Q3 2025 · Sep 30, 2025 $10.42M
Total Assets Q3 2025 · Dec 31, 2024 $9.58M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.92
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.29
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.43
Eps Basic Q3 2025 · Sep 30, 2025 −$0.30
Eps Basic Q3 2025 · Sep 30, 2025 −$0.92
Eps Basic Q3 2025 · Sep 30, 2024 −$0.29
Eps Basic Q3 2025 · Sep 30, 2024 −$1.43
Sga Expense Q3 2025 · Sep 30, 2025 $1.53M
Sga Expense Q3 2025 · Sep 30, 2025 $4.74M
Sga Expense Q3 2025 · Sep 30, 2024 $1.24M
Sga Expense Q3 2025 · Sep 30, 2024 $4.09M
Rd Expense Q3 2025 · Sep 30, 2025 $348K
Rd Expense Q3 2025 · Sep 30, 2025 $440K
Rd Expense Q3 2025 · Sep 30, 2024 $81K
Rd Expense Q3 2025 · Sep 30, 2024 $230K
Net Income Q3 2025 · Sep 30, 2025 −$976K
Net Income Q3 2025 · Sep 30, 2025 −$2.73M
Net Income Q3 2025 · Jun 30, 2025 −$324K
Net Income Q3 2025 · Mar 31, 2025 −$1.43M
Net Income Q3 2025 · Sep 30, 2024 −$723K
Net Income Q3 2025 · Sep 30, 2024 −$3.59M
Net Income Q3 2025 · Jun 30, 2024 −$1.32M
Net Income Q3 2025 · Mar 31, 2024 −$1.54M
Operating Income Q3 2025 · Sep 30, 2025 −$1.01M
Operating Income Q3 2025 · Sep 30, 2025 −$4.14M
Operating Income Q3 2025 · Sep 30, 2024 −$1.13M
Operating Income Q3 2025 · Sep 30, 2024 −$4.13M